In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
484 News Items found
MSK clinical geneticist Kenneth Offit and genetic counselor Yelena Kemel pictured in a laboratory
In the Clinic
Testing for BRCA: What Is the Best Way to Screen for Cancer Genes?

The BRCA Founder Outreach study was recently launched to look at how patients undergo genetic screenings for cancer.
Surgeon-scientist Vinod Balachandran in the laboratory
Q&A
What To Know About Pancreatic Cancer

Learn about important advances in the treatment of pancreatic cancer.
Dr. Urvi Shah is seen smiling at the camera.
MSK Research Reveals Connection Between Diet and Cancer

Learn more about how a clinical trial at MSK revealed important connections between the foods we eat and our cancer risk.
A micrograph image of breast cancer cells.
In the Lab
Research Reveals How Sleeping Cancer Cells Wake Up

MSK investigators are studying how dormant cancer cells can become reactivated after remaining hidden in the body for years.
MSK patient Ellen Coopersmith smiling in a rowboat in Central Park
MSK-Led Research Resulted in New FDA Approvals for Cancer Drugs in 2025

Learn about the clinical trials and research at MSK that led to FDA approvals in 2025, expanding treatment options for a range of different cancers.
Larry Norton, MD, and Hedvig Hricak, MD, PhD
MSK Researchers Use Simulation-Based Analysis to Estimate Increase in Breast Cancer Survival Worldwide Through Scale-up of Treatment and Early Detection

Memorial Sloan Kettering Cancer Center researchers join with experts from international institutions to estimate the potential impact of scaling up the availability of treatment and imaging modalities on breast cancer survival globally, together with improvements in quality of care.
Man and woman in white lab coats looking at test tubes
In the Clinic
Single-Cell Analysis Enables Researchers to Understand the Differences within Tumors

Scientists are decoding the genetic changes that drive individual cancer cells. This may help them develop more-effective targeted therapies.
Crowded hall with ASCO signage
Roundup
Highlights from ASCO 2018: Immunotherapy for Endometrial Cancer, Benefits of Exercise, and Promising New Targeted Drugs

Couldn't make it to the American Society of Clinical Oncology's annual meeting this year? Read this summary of some main takeaways.
Close up of microscope viewer.
Article
MSK Research Highlights, October 15, 2024

New MSK research identifies a gene mutation associated with resistance to breast cancer treatment; reports encouraging results for expanding use of a new prostate cancer radiotherapy; determines the best radiation level for avoiding complications treating spinal tumors; and finds that proton therapy is effective against previously treated head and neck cancers.
Memorial Sloan Kettering Researcher Examines Disparity in Job Retention in Breast Cancer Patients

Breast cancer affects one in eight women in the United States, with approximately 70 to 80 percent of employed breast cancer survivors returning to work three to eighteen months following diagnosis. Job loss can have devastating financial consequences, including increased risk of bankruptcy and debt. Victoria Blinder, MD, medical oncologist at Memorial Sloan Kettering, conducted a longitudinal study of a racially and ethnically diverse sample of employed women undergoing treatment for stage I-III breast cancer in New York City. For more information on this study, published in <i>Health Affairs</i> on February 6, 2017, and to speak with the study author, contact [email protected].